Carcinoid Tumor Clinical Trials Carcinoid Tumor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Condition:   Carcinoid TumorsInterventions:   Drug: Ramucirumab;   Drug: Somatostatin AnalogSponsors:   Dana-Farber Cancer Institute;   Eli Lilly and CompanyNot yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2016 Category: Research Source Type: clinical trials